Key result
Study evaluates clinical responses to adenovirus 26 and 27 cross-challenges in conjunctivitis and enteric infection.
Authors
Loading...
Does not support changes in adenovirus management; leaves open optimal serotype coverage for vaccines.
Key points are not available for this paper at this time.
Kasel et al. (1963) studied this question. Adenovirus types 26 and 27 were evaluated for clinical responses to primary, secondary, and reciprocal cross-challenges in relation to conjunctivitis and enteric infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: